Market Cap

Ultimovacs ASA Market Capitalization:

kr275.6 Million

NOK as of July 1, 2024

US$25.9 Million

business Ultimovacs ASA Company Profile

Ultimovacs ASA Main Stock Listing

OSE: ULTI

Market Capitalization History of Ultimovacs ASA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Ultimovacs ASA market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr4.47 B 17.39%
Jan. 1, 2023 kr3.80 B 7.87%
Jan. 1, 2022 kr3.53 B 36.19%
Jan. 1, 2021 kr2.59 B 38.15%
Jan. 1, 2020 kr1.87 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Ultimovacs ASA Categories

languages Healthcare languages Biotechnology

Stocks & Indices

Ultimovacs ASA has the following listings and related stock indices.


Stock: OSE: ULTI

Stock: FSX: 7UM

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.